Caseware UK (AP4) 2019.0.131 2019.0.131 2019-03-31 2019-03-31 true true true true true true true 2018-04-01 false false 06889809 2018-04-01 2019-03-31 06889809 2017-07-01 2018-03-31 06889809 2019-03-31 06889809 2018-03-31 06889809 2017-07-01 06889809 c:CompanySecretary1 2018-04-01 2019-03-31 06889809 c:Director1 2018-04-01 2019-03-31 06889809 c:Director2 2018-04-01 2019-03-31 06889809 c:Director3 2018-04-01 2019-03-31 06889809 c:RegisteredOffice 2018-04-01 2019-03-31 06889809 d:FurnitureFittings 2018-04-01 2019-03-31 06889809 d:FurnitureFittings 2019-03-31 06889809 d:FurnitureFittings 2018-03-31 06889809 d:CurrentFinancialInstruments 2019-03-31 06889809 d:CurrentFinancialInstruments 2018-03-31 06889809 d:CurrentFinancialInstruments d:WithinOneYear 2019-03-31 06889809 d:CurrentFinancialInstruments d:WithinOneYear 2018-03-31 06889809 d:ShareCapital 2018-04-01 2019-03-31 06889809 d:ShareCapital 2019-03-31 06889809 d:ShareCapital 2017-07-01 2018-03-31 06889809 d:ShareCapital 2018-03-31 06889809 d:ShareCapital 2017-07-01 06889809 d:SharePremium 2018-04-01 2019-03-31 06889809 d:SharePremium 2019-03-31 06889809 d:SharePremium 2017-07-01 2018-03-31 06889809 d:SharePremium 2018-03-31 06889809 d:SharePremium 2017-07-01 06889809 d:RetainedEarningsAccumulatedLosses 2018-04-01 2019-03-31 06889809 d:RetainedEarningsAccumulatedLosses 2019-03-31 06889809 d:RetainedEarningsAccumulatedLosses 2017-07-01 2018-03-31 06889809 d:RetainedEarningsAccumulatedLosses 2018-03-31 06889809 d:RetainedEarningsAccumulatedLosses 2017-07-01 06889809 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2019-03-31 06889809 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2018-03-31 06889809 d:FinancialLiabilitiesFairValueThroughProfitOrLoss d:UnlistedNon-exchangeTraded 2019-03-31 06889809 d:FinancialLiabilitiesFairValueThroughProfitOrLoss d:UnlistedNon-exchangeTraded 2018-03-31 06889809 c:FRS102 2018-04-01 2019-03-31 06889809 c:Audited 2018-04-01 2019-03-31 06889809 c:FullAccounts 2018-04-01 2019-03-31 06889809 c:PrivateLimitedCompanyLtd 2018-04-01 2019-03-31 06889809 c:PublicLimitedCompanyPLCNotQuotedOnAnyExchange 2018-04-01 2019-03-31 06889809 d:Subsidiary1 2018-04-01 2019-03-31 06889809 d:Subsidiary1 1 2018-04-01 2019-03-31 06889809 2 2018-04-01 2019-03-31 06889809 6 2018-04-01 2019-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number:  06889809









APM HEALTHCARE LIMITED









DIRECTORS' REPORT AND FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 MARCH 2019

 
APM HEALTHCARE LIMITED
 
 
COMPANY INFORMATION


Mr J C Patel Jnr  
Mr K C Patel Jnr  
Miss H Patel  




A R Patel



06889809



2 Peterwood Way

Croydon

Surrey

CR0 4UQ




KPMG LLP, Statutory Auditor
Chartered Accountants

1 Forest Gate

Brighton Road

Crawley

RH11 9PT





 
APM HEALTHCARE LIMITED
 

CONTENTS



Page
Directors' report
1 - 2
Independent auditor's report to the Members of APM Healthcare Limited
3 - 5
Statement of comprehensive income
6
Statement of financial position
7
Statement of changes in equity
8
Notes to the financial statements
9 - 17


 
APM HEALTHCARE LIMITED
 
 
DIRECTORS' REPORT
FOR THE PERIOD ENDED 31 MARCH 2019

The directors present their report and the financial statements for the period ended 31 March 2019 comparative
9 month period ended 31 March 2018.


The directors are responsible for preparing the Directors' report and the  financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year . Under that law they have elected to prepare the financial statements in accordance with UK accounting standards and applicable law (UK Generally Accepted Accounting Practice), including FRS 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
 
 Under company law the directors must not approve the financial statements unless they are satisfied that they give
 a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:


select suitable accounting policies and then apply them consistently;

make judgments and estimates that are reasonable and prudent;

state whether applicable UK accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements;

assess the company’s ability to continue as a going concern, disclosing, as applicable, matters related to   going concern; and.

use the going concern basis of accounting unless they either intend to liquidate the company or to cease   operations, or have no realistic alternative but to do so.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006.  They are responsible for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error, and have general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the company and to prevent and detect fraud and other irregularities.


The principal activity of the company continued to be that of the provision of consultancy services relevant to the pharmacy industry.


The directors who served during the period were:

Mr K C Patel Jnr  
Miss H Patel  


Page 1

 
APM HEALTHCARE LIMITED
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2019


Each of the persons who are  directors at the time when this Directors' report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditor is unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditor is aware of that information.


The auditor, KPMG LLP, Statutory Auditorwill be proposed for reappointment in accordance with  section 485 of the Companies Act 2006.


In preparing this report, the directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 





Mr J C Patel Jnr
Director

Date:  23 September 2019

2 Peterwood Way
Croydon
Surrey
CR0 4UQ

Page 2

 





INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF APM HEALTHCARE LIMITED
 


Opinion 

We have audited the financial statements of APM Healthcare Limited (“the company”) for the period ended 31 March 2019 which comprise the Profit and Loss Account, Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity, and related notes, including the accounting policies in note 2 

In our opinion the financial statements: 

give a true and fair view of the state of the company’s affairs as at 31 March 2019 and of its loss for the year then ended; 

have been properly prepared in accordance with UK accounting standards, including FRS 102  The Financial Reporting Standard applicable in the UK and Republic of Ireland ; and 

have been prepared in accordance with the requirements of the Companies Act 2006.  

Basis for opinion 

We conducted our audit in accordance with International Standards on Auditing (UK) (“ISAs (UK)”) and applicable law.  Our responsibilities are described below.  We have fulfilled our ethical responsibilities under, and are independent of the company in accordance with, UK ethical requirements including the FRC Ethical Standard.  We believe that the audit evidence we have obtained is a sufficient and appropriate basis for our opinion.  

The impact of uncertainties due to the UK exiting the European Union on our audit

Uncertainties related to the effects of Brexit are relevant to understanding our audit of the financial statements. All audits assess and challenge the reasonableness of estimates made by the directors, such as recoverability of certain assets and related disclosures and the appropriateness of the going concern basis of preparation of the financial statements. All of these depend on assessments of the future economic environment and the company’s future prospects and performance. 

Brexit is one of the most significant economic events for the UK, and at the date of this report its effects are subject to unprecedented levels of uncertainty of outcomes, with the full range of possible effects unknown. We applied a standardised firm-wide approach in response to that uncertainty when assessing the company’s future prospects and performance. However, no audit should be expected to predict the unknowable factors or all possible future implications for a company and this is particularly the case in relation to Brexit.

Going concern 

The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the company or to cease its operations, and as they have concluded that the company’s financial position means that this is realistic. They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements (“the going concern period”).

We are required to report to you if we have concluded that the use of the going concern basis of accounting is inappropriate or there is an undisclosed material uncertainty that may cast significant doubt over the use of that basis for a period of at least a year from the date of approval of the financial statements.  In our evaluation of the directors’ conclusions, we considered the inherent risks to the company’s business model, including the impact of Brexit, and analysed how those risks might affect the company’s financial resources or ability to continue operations over the going concern period.    We have nothing to report in these respects.   
Page 3

 





INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF APM HEALTHCARE LIMITED (CONTINUED)

However, as we cannot predict all future events or conditions and as subsequent events may result in outcomes that are inconsistent with judgements that were reasonable at the time they were made, the absence of reference to a material uncertainty in this auditor's report is not a guarantee that the company will continue in operation.  

Directors’ report  

The directors are responsible for the directors’ report.  Our opinion on the financial statements does not cover that report and we do not express an audit opinion thereon.  

Our responsibility is to read the directors’ report and, in doing so, consider whether, based on our financial statements audit work, the information therein is materially misstated or inconsistent with the financial statements or our audit knowledge.  Based solely on that work:  

we have not identified material misstatements in the strategic report and the directors’ report;  

in our opinion the information given in those reports for the financial year is consistent with the financial statements; and  

in our opinion those reports have been prepared in accordance with the Companies Act 2006.  

Matters on which we are required to report by exception 

Under the Companies Act 2006, we are required to report to you if, in our opinion: 

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors’ remuneration specified by law are not made; or 

we have not received all the information and explanations we require for our audit.

We have nothing to report in these respects.  

Directors' responsibilities

As explained more fully in their statement set out on page 1, the directors are responsible for: the preparation of the financial statements and for being satisfied that they give a true and fair view; such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error; assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and using the going concern basis of accounting unless they either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.    

Auditors' responsibilities

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue our opinion in an auditor’s report.  Reasonable assurance is a high level of assurance, but does not guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists.  Misstatements can arise from fraud or error and are considered material if, individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial statements.

A fuller description of our responsibilities is provided on the FRC’s website at  www.frc.org.uk/auditorsresponsibilities
Page 4

 





INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF APM HEALTHCARE LIMITED (CONTINUED)

The purpose of our audit work and to whom we owe our responsibilities  

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006.  Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose.  To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members, as a body, for our audit work, for this report, or for the opinions we have formed.   




Timothy Rush  (Senior statutory auditor)
  
for and on behalf of
KPMG LLP, Statutory Auditor
 
Chartered Accountants
  
1 Forest Gate
Brighton Road
Crawley
RH11 9PT

24 September 2019
Page 5

 
APM HEALTHCARE LIMITED
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 31 MARCH 2019

Year ended 31 March 2019
Period ended from 1'st July 2017 to 31 March 2018
Note
£
£
   

Turnover
   
-
1,537

Gross profit
   
-
1,537

Administrative expenses
   
(5,499 )
(15,399 )

Operating loss
   
(5,499 )
(13,862 )

Interest receivable and similar income
   
2
161

Interest payable and expenses
   
-
(8,570 )

Loss before tax
   
(5,497 )
(22,271 )

Tax on loss
 5 
-
-

Loss for the financial period
   
(5,497 )
(22,271 )

Other comprehensive income for the period
   
-
-

   

Total comprehensive income for the period
   
(5,497 )
(22,271 )

The notes on pages 9 to 17 form part of these financial statements.

Page 6

 
APM HEALTHCARE LIMITED
REGISTERED NUMBER: 06889809

STATEMENT OF FINANCIAL POSITION
AS AT  31 MARCH 2019

2019
2018
Note
£
£
   

Investments
 7 
100
100

   
100
100

Current assets
   

Debtors: amounts falling due within one year
 8 
2,768,624
2,783,622

Cash at bank and in hand
 9 
9,522
9,069

   
2,778,146
2,792,691

Creditors: amounts falling due within one year
 10 
(2,217,687 )
(2,226,735 )

Net current assets
   
 
 
560,459
 
 
565,956

Total assets less current liabilities
   
560,559
566,056

   

Net assets
   
560,559
566,056

Capital and reserves
   

Called up share capital 
   
174
174

Share premium account
   
615,310
615,310

Profit and loss account
   
(54,925 )
(49,428 )

   
560,559
566,056


The Company's  financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on  23 September 2019 .




Mr J C Patel Jnr
Director

The notes on pages 9 to 17 form part of these financial statements.

Page 7

 
APM HEALTHCARE LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED  31 MARCH 2019


Called up share capital
Share premium account
Profit and loss account
Total equity

£
£
£
£

At 1 April 2018
174
615,310
(49,428 )
566,056



Loss for the period
-
-
(5,497 )
(5,497 )
Total comprehensive income for the period
-
-
(5,497 )
(5,497 )


At 31 March 2019
174
615,310
(54,925 )
560,559



STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED  31 MARCH 2018


Called up share capital
Share premium account
Profit and loss account
Total equity

£
£
£
£

At 1 July 2017
174
615,310
(27,157 )
588,327



Loss for the period
-
-
(22,271 )
(22,271 )
Total comprehensive income for the period
-
-
(22,271 )
(22,271 )


At 31 March 2018
174
615,310
(49,428 )
566,056


The notes on pages 9 to 17 form part of these financial statements.

Page 8

 
APM HEALTHCARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019

General information

APM Healthcare Limited (the “Company”) is a private company limited by shares and incorporated, domiciled and registered in England in the United Kingdom. The address of the registered office is given on company information page. The nature of the company's operations and its principal activities are set out in the director report on page 1.

2. Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in  the UK and the Republic of Ireland and the Companies Act 2006 .

The functional currency of APM Healthcare Limited is considered to be pounds sterling because that is the currency of the primary economic environment in which the company operates. The financial statements are also presented in pounds sterling and rounded to nearest £.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies (see note 3).

The following principal accounting policies have been applied:

2.2

Financial reporting standard 102 - reduced disclosure exemptions

The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.41(b), 11.41(c), 11.41(e), 11.41(f), 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A;
the requirements of Section 26 Share-based Payment paragraphs 26.18(b), 26.19 to 26.21 and 26.23;
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Day Lewis Plc as at 31 March 2019 and these financial statements may be obtained from 2 Peterwood Way, Croydon, Surrey, CR0 4UQ.

2.3

Exemption from preparing consolidated financial statements

The  Company  is a parent  Company  that is also a subsidiary included in the consolidated financial statements of its immediate parent undertaking established under the law of an EEA state and is therefore exempt from the requirement to prepare consolidated financial statements under  section 400 of the Companies Act 2006 .

Page 9

 
APM HEALTHCARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019

2. Accounting policies (continued)

2.4

Interest income

Interest income is recognised in the Statement of comprehensive income using the effective interest method.

2.5

Finance costs

Finance costs are charged to the Statement of comprehensive income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

2.6

Taxation

Tax is recognised in the Statement of comprehensive income, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Fixtures and fittings
-
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of comprehensive income.

2.8

Fixed asset investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of comprehensive income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Page 10

 
APM HEALTHCARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019

2. Accounting policies (continued)

2.9

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

2.11

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

2.12

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

Investments in non-convertible preference shares and in non-puttable ordinary and preference shares are measured:
at fair value with changes recognised in the Statement of comprehensive income if the shares are publicly traded or their fair value can otherwise be measured reliably;
at cost less impairment for all other investments.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.
Page 11

 
APM HEALTHCARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019

2. Accounting policies (continued)

Financial instruments (continued)


For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the reporting date.

Financial assets and liabilities are offset and the net amount reported in the Statement of financial position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

In the application of the company's accounting policies, which are described in note 2, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
There are no critical judgements and estimations that the directors have made in the process of applying the company's accounting policies and that have the most significant effect on the amounts recognised in the financial statements.

The Company has no employees other than the directors, who did not receive any remuneration  (2018 - £ NIL ) .


2019
2018
£
£


Total current tax
-
-

Deferred tax

Total deferred tax
-
-


Taxation on profit on ordinary activities
-
-
Page 12

 
APM HEALTHCARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019
 
5. Taxation (continued)


Factors affecting tax charge for the period

The tax assessed for the period is higher than  (2018 - higher than)  the standard rate of corporation tax in the UK of  19 %  (2018 -  19 %) . The differences are explained below:

2019
2018
£
£


Loss on ordinary activities before tax
(5,497 )
(22,271 )


Loss on ordinary activities multiplied by standard rate of corporation tax in the UK of 19% (2018 - 19%)
(1,044 )
(4,231 )

Effects of:


Group relief
1,044
4,277

Other tax adjustments
-
(46 )

Total tax charge for the period
-
-


Factors that may affect future tax charges

Reductions in the UK corporation tax rate from 19% to 18% (effective from 1 April 2020) were substantively enacted on 26 October 2015. A further reduction to the UK corporation tax rate was announced in the 2016 Budget to further reduce the tax rate to 17% (to be effective from 1 April 2020). This will reduce the company's future current tax charge accordingly.

Page 13

 
APM HEALTHCARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019




Fixtures and fittings

£



Cost


At 1 April 2018
686



At 31 March 2019

686



Depreciation


At 1 April 2018
686



At 31 March 2019

686



Net book value



At 31 March 2019
-



At 31 March 2018
-





Investments in subsidiary companies

£



Cost


At 1 April 2018
100



At 31 March 2019
100




Subsidiary undertaking


Name

Registered office

Class of shares

Holding

Community Pharmacies (UK) Limited
2 Peterwood Way, Croydon, Surrey, CR0 4UQ
Ordinary shares of £1 each
100 %

Page 14

 
APM HEALTHCARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019
2019
2018
£
£


Amounts owed by group undertakings
2,764,326
2,764,764

Amounts owed by joint ventures and associated undertakings
4,298
-

Other debtors
-
18,858

2,768,624
2,783,622


2019
2018
£
£

Cash at bank and in hand
9,522
9,069

9,522
9,069


2019
2018
£
£

Trade creditors
5,006
1,443

Amounts owed to group undertakings
2,205,181
2,207,602

Accruals and deferred income
7,500
17,690

2,217,687
2,226,735


Page 15

 
APM HEALTHCARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019
2019
2018
£
£

Financial assets


Financial assets measured at fair value
9,522
9,069

Financial assets measured at amortised cost
2,768,624
2,783,622

2,778,146
2,792,691


Financial liabilities


Financial liabilities measured at amortised cost
2,217,687
(2,226,735 )

The company has taken advantage of the exemption in section 33 of FRS102 from the requirement to disclose transactions with group companies on the grounds that consolidated financial statements are prepared by the ultimate parent company.
The following entities are all associated companies as they are 50% owned by Community Pharmacies (UK) Limited, a subsidiary of APM Healthcare Limited.
APM Healthcare Limited was owed £3,214 (2018: £5,053) by Priory Fields Healthcare LLP at the year ended 31 March 2019.
APM Healthcare Limited was owed £445 (2018: £445) by Newton Place Healthcare LLP at the year ended 31 March 2019.
APM Healthcare Limited was owed £374 (2018: £374) by Denmark Street Healthcare LLP at the year ended 31 March 2019.
APM Healthcare Limited was owed £265 (2018: £265) by Arlington Road Healthcare LLP at the year ended 31 March 2019.
APM Healthcare Limited was owed £nil (2018: £1,091) by Crewkerne Healthcare LLP at the year ended 31 March 2019.
APM Healthcare Limited was owed £nil (2018: £392) by Stockton Heath Healthcare LLP at the year ended 31 March 2019.

Page 16

 
APM HEALTHCARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019
The company's immediate parent company is Day Lewis plc, a company registered in England and Wales.
It prepares group accounts which are available at Day Lewis House, 2 Peterwood Way, Croydon,Surrey CR0 4UQ.
The ultimate parent company is Day Lewis Holdings Limited, a company registered in Cyprus and controlled by the Kirit Patel Will Trust.

 
Page 17